Skip to main content
. 2019 Jul 15;11(7):336. doi: 10.3390/pharmaceutics11070336

Figure 2.

Figure 2

Final pharmacokinetic(PK) structure developed based on animal PK, where Fmax and F50 is the maximum bioavailability and the amount of dose reaching 50% of the maximum bioavailability, respectively; WB is the time-dependent absorption rate constant following the Weibull distribution α as the scale and β as the shape parameters of the Weibull distribution, respectively; A1, A2, and A3 are the drug amount in the absorption, central, and peripheral compartment, respectively; and CL and Q are the elimination and distribution clearance, respectively.